文献速递头颈部肿瘤放疗胸部肿瘤放疗消化道肿瘤放疗

同步放化疗期间连续活动监测的可行性研究

Continuous Activity Monitoring During Concurrent Chemoradiotherapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2016-12-25

本研究前瞻性纳入38例接受根治性同步放化疗的头颈、肺或消化道肿瘤患者,佩戴活动监测器持续记录步数。

要点

  • 同步放化疗期间连续活动监测可行且耐受良好,94%治疗日可获得步数数据
  • 生活质量和体能状态评分未显示与住院风险增加相关

核心结论

  • 同步放化疗期间连续活动监测可行且耐受良好,步数可作为住院风险的客观动态指标。

研究设计与样本

  • 前瞻性试验纳入38例计划接受根治性同步放化疗的头颈、肺或消化道肿瘤门诊患者,治疗前提供活动监测器并要求全程佩戴。
  • 主要目标为可行性,定义为收集研究受试者放疗期间80%天数的步数数据;次要目标包括确立步数作为非计划住院风险的动态预测指标。

主要发现

  • 38例患者中头颈癌11例、肺癌13例、消化道肿瘤14例。
  • 放疗期间1613天中有1524天(94%)收集到步数数据。
  • 14例患者在放疗期间或放疗完成后4周内住院。
  • 较差的生活质量评分和受损的体能状态与住院风险增加无关。

关键数值与推荐

  • 可行性定义为收集研究受试者放疗期间80%天数的步数数据,实际达到94%(1524/1613天)。

临床怎么用

  • 对接受根治性同步放化疗的头颈、肺或消化道肿瘤门诊患者,可考虑使用活动监测器连续记录步数。
  • 步数下降可能提示住院风险升高,可作为客观动态指标辅助临床监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To perform a prospective trial testing the feasibility and utility of acquiring activity data as a measure of health status during concurrent chemoradiotherapy. METHODS AND MATERIALS: Ambulatory patients who were planned for treatment with concurrent chemoradiotherapy with curative intent for cancers of the head and neck, lung, or gastrointestinal tract were provided with activity monitors before treatment initiation. Patients were asked to wear the devices continuously throughout the radiation therapy course. Step count data were downloaded weekly during radiation therapy and 2 and 4 weeks after radiation therapy completion. The primary objective was to demonstrate feasibility, defined as collection of step counts for 80% of the days during study subjects' radiation therapy courses. Secondary objectives included establishing step count as a dynamic predictor of unplanned hospitalization risk. RESULTS: Thirty-eight enrolled patients were treated with concurrent chemoradiotherapy. Primary diagnoses included head and neck cancer (n=11), lung cancer (n=13), and a variety of gastrointestinal cancers (n=14). Step data were collected for 1524 of 1613 days (94%) during patients' radiation therapy courses. Fourteen patients were hospitalized during radiation therapy or within 4 weeks of radiation therapy completion. Cox regression modeling demonstrated a significant association between recent step counts (3-day average) and hospitalization risk, with a 38% reduction in the risk of hospitalization for every 1000 steps taken each day (hazard ratio 0.62, 95% confidence interval 0.46-0.83, P=.002). Inferior quality of life scores and impaired performance status were not associated with increased hospitalization risk. CONCLUSION: Continuous activity monitoring during concurrent chemoradiotherapy is feasible and well-tolerated. Step counts may serve as powerful, objective, and dynamic indicators of hospitalization risk.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Ohri N, Kabarriti R, Bodner WR, et al. Continuous Activity Monitoring During Concurrent Chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2016. PMID: 28332990. doi:10.1016/j.ijrobp.2016.12.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。